Category: United States
-
BREAKING: USITC orders import ban on Innoscience products over infringement of Infineon gallium nitride patent
China’s Innoscience will be prohibited from importing its infringing products into the U.S. market – though the multi-jurisdiction battle with Infineon looks set to continue.
-
District judge opens door to rare “reverse doctrine of equivalents” defense in medical device dispute
The judge’s order came amid long-running litigation between Maquet and Abiomed in the United States District Court for the District of Massachusetts over intravascular blood pump technologies.
-
“About this much”, is how much? Federal Circuit affirms poultry-processing patent invalidity over “vague, indefinite” pH claims
The decision underlines the need for appropriate precision and detail in patent claims that are quantitative in nature.
-
USITC seeks input on proposed new rules around real-party-in-interest disclosures
The proposed rulemaking fits with the trend seen across agencies dealing with U.S. patent matters, where there is a push for more transparency around real-parties-in-interest.
-
IPR petitions hit lowest-ever monthly total in April as new USPTO policies take hold
Meanwhile, requests for ex parte re-examination have skyrocketed to their highest number in years.
-
Patents out, trade secrets in: Celonis seeks to reshape SAP fight in California
Celonis plans to modify its antitrust lawsuit in California against SAP to add trade secret allegations stemming from discovery, igniting a discussion about the relevance of new IP claims in the case.
-
Federal Circuit analysis would create “substantial disincentive” to generic entry, USDOJ tells Supreme Court in Hikma v. Amarin
The key arguments centred on whether it was plausible that Hikma’s marketing amounted to inducement to infringe.
-
First U.S. SEP injunction since 2007 now unlikely: Wilus v. Askey & Samsung pretrial conference gets canceled on short notice
On Tuesday, Judge Gilstrap first modified the time of a Wilus v. Askey & Samsung pretrial conference, and later in the day canceled it altogether. Some interesting motions are now unlikely ever to be adjudicated.
-
FedEx can fight another day in Qualcomm dispute, as Federal Circuit considers IPR real-parties-in-interest
The USPTO withdrew its initial defense of the PTAB’s refusal of FedEx’s arguments around real parties in interest.